Innate Pharma SA
Last · —$1.43-0.04 (-2.72%)live · yahoo · 2h ago
Vol 4.8K ≈ 7.6K
MA10MA20MA50
Market cap$159.73M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameInnate Pharma SA
HQUnited States (US)
ListingUS IPHA
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001598599
CIK0001598599
Websitewww.innate-pharma.com
Loading chart…
Upcoming earnings
THU.5NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.15
Est. revenue
2.3M
Earnings transcripts
- Motley Fool
Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript
Innate Pharma SA
- Issuer webcast
Q2 2026 earnings call transcript
Innate Pharma SA
- Issuer webcast
Q1 2026 earnings call transcript
Innate Pharma SA
- Issuer webcast
Q3 2025 earnings call transcript
Innate Pharma SA
- Issuer webcast
Q2 2025 earnings call transcript
Innate Pharma SA
- Issuer webcast
Q1 2025 earnings call transcript
Innate Pharma SA
Documents
FormReporting forFiledFlags
Showing 5 of 114 filings